Literature DB >> 3584970

Immunoregulation by antigen/antibody complexes. I. Specific immunosuppression induced in vivo with immune complexes formed in antibody excess.

M J Caulfield, D Shaffer.   

Abstract

Specific immune complexes, prepared at different ratios of antibody to antigen, were examined for their effects on the antibody response of BALB/c mice to the cell wall polysaccharide antigen (PnC) extracted from Streptococcus pneumonia R36a. Mice immunized with complexes formed in antigen excess developed a PnC-specific antibody response that was equivalent to that in mice injected with free antigen. On the other hand, mice injected with complexes formed in antibody excess developed very little PnC-specific antibody. Furthermore, administration of immune complexes (formed in antibody excess) resulted in suppression of the response to an immunogenic dose of PnC given concurrently or 1 day after injection of immune complexes but not when the antigen was given 1 day before injection of the immune complexes. Injections of free antibody (TEPC-15) also resulted in suppression of the response to antigenic challenge; however, suppression was greatest when the antibody was injected concurrently with the antigen, suggesting that the suppression was mediated through the formation of immune complexes in vivo. The suppression appears to be specific for the antigen (PnC), since in mice injected with TEPC-15/PnC complexes (formed in antibody excess) and challenged with PnC coupled to sheep RBC, only the response to PnC was suppressed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584970

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.

Authors:  L Jeannine Brady
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 2.  FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.

Authors:  Michal Pyzik; Timo Rath; Wayne I Lencer; Kristi Baker; Richard S Blumberg
Journal:  J Immunol       Date:  2015-05-15       Impact factor: 5.422

3.  Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody Response.

Authors:  Michael D Hambuchen; F Ivy Carroll; Daniela Rüedi-Bettschen; Howard P Hendrickson; Leah J Hennings; Bruce E Blough; Lawrence E Brieaddy; Ramakrishna R Pidaparthi; S Michael Owens
Journal:  J Med Chem       Date:  2015-05-22       Impact factor: 7.446

4.  Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes.

Authors:  J J Machiels; M A Somville; P M Lebrun; S J Lebecque; M G Jacquemin; J M Saint-Remy
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

5.  Recruitment of virgin B cells into an immune response is restricted to activation outside lymphoid follicles.

Authors:  D Gray
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

Review 6.  Is infant immunization by breastfeeding possible?

Authors:  Valerie Verhasselt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

7.  Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.

Authors:  Georgios Tsouchnikas; Juergen Zlatkovic; Johanna Jarmer; Judith Strauß; Oksana Vratskikh; Michael Kundi; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

8.  Demonstration of circulating pneumococcal immunoglobulin G immune complexes in patients with community-acquired pneumonia by means of an enzyme-linked immunosorbent assay.

Authors:  Y Holloway; J A Snijder; W G Boersma
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

9.  Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.

Authors:  G B Pier; S Takeda; M Grout; R B Markham
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection.

Authors:  Natalie E Stevens; Antoinette Hatjopolous; Cara K Fraser; Mohammed Alsharifi; Kerrilyn R Diener; John D Hayball
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.